Hematology & Oncology Doctors in Lynchburg, VA Accepting Medicare

4 Hematology & Oncology doctors found. Showing 1 - 4

Dr. Emaculate Verla Tebit, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 Thomson Dr, Suite 200, Lynchburg, VA 24501 Phone: 434-200-5295

Amir M. Khan, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 Thomson Dr, Lynchburg, VA 24501 Phone: 434-200-4522

Dr. Mahmood Rasheed, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 Thomson Dr, Lynchburg, VA 24501 Phone: 434-200-4522

Dr. Emily O Jenkins, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1701 Thomson Dr, Suite 200, Lynchburg, VA 24501 Phone: 434-200-5925    Fax: 434-200-5929

News Archive

Scientists explore development of unique dentition of 'toothed whales'

Whales are mammals, but they don't look like the mammals living around us, as they have a triangular fluke for tail, no hind legs and no body hair. And inside their mouths, their teeth are unfamiliar too - being much simpler and 'peg like'. A multidisciplinary team of researchers have now married together the fossil record and the embryonic development process to investigate how the whale got its teeth.

Study describes new targets for precision treatment of meningiomas

Winner of the Integra Foundation Award, Mark W. Youngblood, presented his research, Clinical and Molecular Features of Genomic Subgroups in Meningioma, during the 2017 American Association of Neurological Surgeons Annual Scientific Meeting.

GSK confirms FDA advisory committees' vote to allow Avandia to remain on the market

GlaxoSmithKline confirmed today that a joint advisory committee to the U.S. Food and Drug Administration (FDA) voted to allow Avandia to remain on the market. Committee members voted for recommendations ranging from making no changes to the current label, to revising the label with additional warnings and restrictions to withdrawal from the U.S. market.

Study identifies cluster of dysregulated genes in pancreatic islets of type 2 diabetes patients

Type 2 diabetes, which affects >0.5 billion people worldwide, results from the inability of beta cells in the pancreatic islets to provide the body with enough insulin to maintain blood glucose levels within the range for a healthy life.

Read more Medical News

› Verified 1 days ago